109381 ⎘
Active agents used in cell culture processes, e.g. differentation; Regulators of development Regulators of apoptosis
ALTERING GENE EXPRESSION IN CART CELLS AND USES THEREOF
#2USE OF HUMAN PLATELET-APOPTOTIC VESICLES
#3SELECTIVE TOLERIZATION - METHODS OF SELECTIVELY GENERATING TOLEROGENIC DENDRITIC CELLS
#4GENETICALLY MODIFIED NK-92 CELL LINE
#5CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#6METHODS TO ENHANCE TUMOR IMMUNOGENICITY AND COMPOSITIONS FOR AUTOLOGOUS CANCER IMMUNOTHERAPEUTIC PRODUCTS USING MODIFIED TUMOR CELLS AND MODIFIED DENDRITIC CELLS
#7METHOD AND CULTURE MEDIUM FORMULATION WHICH CAN BE USED TO OBTAIN MOTOR NEURONS FROM PLURIPOTENT STEM CELL-DERIVED NEUROMESODERMAL STEM CELLS
#8PRODUCTION METHOD FOR T CELLS OR NK CELLS, MEDIUM FOR CULTURING T CELLS OR NK CELLS, METHOD FOR CULTURING T CELLS OR NK CELLS, METHOD FOR MAINTAINING UNDIFFERENTIATED STATE OF UNDIFFERENTIATED T CELLS, AND GROWTH-ACCELERATING AGENT FOR T CELLS OR NK CELLS
#9CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#10MEDIA AND METHODS FOR MAKING AND MAINTAINING PORCINE PLURIPOTENT STEM CELLS
#11Altering Gene Expression in CART Cells and Uses Thereof
#12METHODS AND COMPOSITIONS FOR PROMOTING NON-NATURAL AMINO ACID-CONTAINING PROTEIN PRODUCTION
#13NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS
#14COMPOSITION AND METHODS OF GENOME EDITING OF B-CELLS
#15METHODS FOR INDUCING SELECTIVE APOPTOSIS
#16Methods of preparing a primary cell sample
#17Recombinant PD-L1 peptides and methods of use
#18Interleukin-4 Receptor-Binding Fusion Proteins and Uses Thereof
#19Methods to Enhance Tumor Immunogenicity and Compositions for Autologous Cancer Immunotherapeutic Products Using Modified Tumor Cells and Modified Dendritic Cells
#20METHOD FOR INDUCING ANTIGEN SPECIFIC CD8 POSITIVE T CELLS
#21EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS
#22Altering Gene Expression in Modified T Cells and Uses Thereof
#23Altering Gene Expression in Modified T Cells and Uses Thereof
#24MODIFIED IMMUNE EFFECTOR CELLS WITH INCREASED RESISTANCE TO CELL DEATH
#25METHODS FOR ENHANCING DIRECT REPROGRAMMING OF CELLS
#26GENETICALLY MODIFIED NK-92 CELLS HAVING A SAFETY SWITCH
#27Production method for T cells or NK cells, medium for culturing T cells or NK cells, method for culturing T cells or NK cells, method for maintaining undifferentiated state of undifferentiated T cells, and growth-accelerating agent for T cells or NK cells
#28PRODUCTION METHODS FOR MEGAKARYOCYTES AND PLATELETS
#29DEVICES AND METHODS FOR PRODUCTION OF CELL AGGREGATES
#30MODULATION OF APOPTOSIS SUSCEPTIBLE CELLS
#31Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
#32Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased Cytotoxicity
#33METHODS FOR EXP ANDING ADIPOSE-DERIVED STEM CELLS
#34Inducing cell death by hyperactivation of motility networks
#35PRODUCTION AND USE OF RED BLOOD CELLS
#36FIXED RATIO EX VIVO ACTIVATED MIXED LYMPHOCYTE PRODUCTS FOR USE IN THE TREATMENT OF CANCER
#37Methods and compositions for promoting non-natural amino acid-containing protein production
#38Altering Gene Expression in CART Cells and Uses Thereof
#39Method for producing chimeric animal
#40Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
#41Methods to Enhance Tumor Immunogenicity and Compositions for Autologous Cancer Immunotherapeutic Products Using Modified Tumor Cells and Modified Dendritic Cells
#42Methods for inducing partial apoptosis using caspase polypeptides
#43CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#44METHODS FOR ELIMINATING AT LEAST A SUBSTANTIAL PORTION OF A CLONAL ANTIGEN-SPECIFIC MEMORY T CELL SUBPOPULATION
#45METHODS FOR INDUCING SELECTIVE APOPTOSIS
#46COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION
#47EMBRYONIC STEM CELL MEDIA AND CULTURE
#48Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
#49DEVICES AND METHODS FOR PRODUCTION OF CELL AGGREGATES
#50Compositions and methods for inducing thrombopoiesis
#51Method for inducing antigen specific CD8 positive T cells
#52Interleukin-4 receptor-binding fusion proteins and uses thereof
#53Interleukin-4 receptor-binding fusion proteins and uses thereof
#54Inducing cell death by hyperactivation of motility networks
#55COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY ARTHRITIS
#56Conditionally immortalized long-term stem cells and methods of making and using such cells
#57Method for producing chimeric animal
#58Modified natural killer cells and natural killer cell lines having increased cytotoxicity
#59Altering gene expression in modified T cells and uses thereof
#60Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients
#61METHODS FOR INDUCING SELECTIVE APOPTOSIS
#62SYSTEM FOR IMMUNOTHERAPY TARGETING TUMOR PROPAGATION AND PROGRESSION
#63Methods for inducing selective apoptosis
#64Methods for inducing partial apoptosis using caspase polypeptides
#65Methods of preparing a primary cell sample
#66Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
#67Production and use of red blood cells
#68Method for inducing differentiation of neural crest cells into neurons of the autonomic nervous system
#69TREATMENT OF PLURIPOTENT CELLS
#70Method for producing polyploidized megakaryocyte and platelets
#71Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#72Altering Gene Expression in CART Cells and Uses Thereof
#73Composition for collecting and preserving placental stem cells and methods of using the composition
#74Altering gene expression in modified T cells and uses thereof
#75Cardiomyocyte production
#76Methods and Compositions for the Generation and Maintenance of Regulatory T Cells
#77Composition including Stem Cell-Derived Exosome for Inducing Adipogenic Differentiation and Adipose Tissue Regeneration
#78METHODS FOR ELIMINATING AT LEAST A SUBSTANTIAL PORTION OF A CLONAL ANTIGEN-SPECIFIC MEMORY T CELL SUBPOPULATION
#79NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS
#80Vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells
#81Trans-differentiation of differentiation cells
#82Expansion of adult stem cells in vitro
#83UNIVERSAL DONOR CHIMERIC ANTIGEN RECEPTOR CELLS
#84Interleukin-4 receptor-binding fusion proteins and uses thereof
#85Generation of lineage-restricted progenitor cells from differentiated cells
#86Interleukin-4 receptor-binding fusion proteins and uses thereof
#87System for immunotherapy targeting tumor propagation and progression
#88Methods for inducing partial apoptosis using caspase polypeptides
#89METHOD FOR GENERATING CARDIOMYOCYTES
#90Method for producing differentiated cells
#91Heterocyclic compounds useful for kinase inhibition
#92METHOD FOR PRODUCING CHIMERIC ANIMAL
#93Method for inducing hemoblast differentiation
#94Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#95Culture medium and method for inducing differentiation of pluripotent stem cells to hepatoblasts
#96CONDITIONALLY IMMORTALIZED LONG-TERM STEM CELLS AND METHODS OF MAKING AND USING SUCH CELLS
#97Method for enhancing a function of a T cell
#98Methods and compositions for inducing apoptosis by stimulating ER stress
#99Methods for inducing selective apoptosis
#100OVARIAN CANCER VACCINES AND VACCINATION METHODS
#101Z cells activated by zinc finger-like protein and uses thereof in cancer treatment
#102Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#103Conditionally immortalized long-term stem cells and methods of making and using such cells
#104Cardiomyocyte production
#105Heterocyclic compounds useful for kinase inhibition
#106Methods for reducing and/or preventing excessive cellular apoptosis
#107Method of producing induced pluripotent stem cells using inhibitors of P53
#108Compositions and methods for inducing thrombopoiesis
#109Methods for treating polycystic kidney disease and polycystic liver disease
#110Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#111Production and use of red blood cells
#112Method for preparing corneal endothelial cell
#113Method for producing polyploidized megakaryocyte and platelets
#114Treatment of pluripotent cells
#115System for immunotherapy targeting tumor propagation and progression
#116Cardiomyocyte production
#117Parstatin peptides
#118Regulatory immune cells with enhanced targeted cell death effect
#119Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#120MicroRNA Mediated Neuronal Cell Induction
#121Engineered Xenogeneic Cells for Repair of Biological Tissue
#122Method for producing differentiated cells
#123Methods of producing antigen-specific B cell populations in the presence of CD40:CD40L, BAFF:BAFF receptor and Fas:FasL stimulation
#124Method of producing induced pluripotent stem cells using inhibitors of P53
#125Mammalian cell lines for increasing longevity and protein yield from a cell culture
#126Methods of using death receptor agonists and EGFR inhibitors
#127Mammalian cell lines for increasing longevity and protein yield from a cell culture
#128Methods and compositions for the generation and maintenance of regulatory T cells
#129Methods for improving viability and productivity in cell culture
#130TREATING CANCER WITH CARDIAC GLYCOSIDES
#131Method for enhancing a function of a T cell
#132Methods and compositions for inducing apoptosis by stimulating ER stress
#133Methods for inducing selective apoptosis
#134THE SECRETORY CAPACITY IN HOST CELLS
#135Methods for Protein Expression in Mammalian Cells in Serum-Free Medium
#136CD20 antibodies and uses thereof
#137Cardiomyocyte production
#138DEVICES AND METHODS FOR PRODUCTION OF CELL AGGREGATES
#139Diagnosing and treating hormone resistant cancers
#140Small molecule inhibitors of MDM2 and the uses thereof
#141Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells
#142Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture
#143Mammalian cell lines for increasing longevity and protein yield from a cell culture
#144Conditionally immortalized long-term stem cells and methods of making and using such cells
#145THERAPY OR PREVENTION OF DISEASES WITH CELLS OR CELL SUPERNATANT
#146Composition for collecting and preserving placental stem cells and methods of using the composition
#147Compositions and methods for treating inflammatory arthritis
#148IMMUNOCOMPETENT CELL HAVING ANTI-CD38 ANTIBODY ON ITS CELL SURFACE
#149Application of Anti-Apoptotic Gene Expression in Mammalian Cells for Perfusion Culture
#150Methods for making recombinant proteins using apoptosis inhibitors
#151DEVICES AND METHODS FOR PRODUCTION OF CELL AGGREGATES
#152Novel Compositions and Uses Thereof
#153Methods for Improving Viability and Productivity in Cell Culture
#154Methods and compositions for generation of Bax-and Bak-deficient cell lines
#155Treatment of pluripotent cells
#156Methods for Obtaining High Viable Cell Density in Mammalian Cell Culture
#157Novel apoptosis inducing factor and method of inducing apoptosis using the same
#158In vitro fertilisation
#159METHODS AND COMPOSITIONS FOR ENHANCING DEVELOPMENTAL POTENTIAL OF OOCYTES AND PREIMPLANTATION EMBRYOS
#160Materials and methods relating to the production and maintenance of cell lines
#161Mammalian cell lines for increasing longevity and protein yield from cell culture
#162Oligodendrocyte precursor cell composition and methods of use
#163Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
#164Peroxisome proliferator-activator receptor δ (PPARδ) and the development of preimplantation embryos
#165Methods of Using Death Receptor Agonists and EGFR Inhibitors
#166Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulation
#167Methods for protein expression in mammalian cells in serum-free medium
#168USE OF EIF-5A1 SIRNA TO PROTECT ISLETS CELLS FROM APOPTOSIS AND TO PRESERVE THEIR FUNCTIONALITY
#169Methods and compositions for including apoptosis by stimulating ER stress
#170Tumor suppressor protein and nucleotide encoding same
#171Diagnosing and treating hormone resistant cancers
#172TREATING CANCER WITH CARDIAC GLYCOSIDES
#173βGBP, compositions comprising βGBP, and related methods and uses thereof
#174Use of Sirnas in Organ Storage/Reperfusion Solutions
#175Bioactive parstatin peptides and methods of use
#176Methods for Inducing the Differentiation of Blood Monocytes into Functional Dendritic Cells
#177Acid ceramidase and mammalian cell survival
#178Methods of Using Apo2l Receptor Agonists and Ink Cell Activators
#179Apoptin-associating protein
#180Method of growing an artery
#181Apoptin-associating protein
#182Method and apparatus for installation of dental implant
#183Method and apparatus for installation of dental implant
#184Tumor-Homing Cells Engineered to Produce Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) by Adenoviral-Mediated Gene Transfer
#185Use of lacritin in promoting ocular cell survival
#186Immune Modulation By Regulating Expression Of The "Minor" Gene In Immune Dendritic Cells
#187Composition for collecting placental stem cells and methods of using the composition
#188Control of proliferation and apoptosis in cancer cells
#189Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells
#190Systems and methods for selection and maintenance of homogeneous and pluripotent human embryonic stem cells
#191Method and apparatus for installation of dental implant
#192Method and apparatus for installation of dental implant
#193Mammalian cell lines for increasing longevity and protein yield from a cell culture
#194Methods for making recombinant proteins using apoptosis inhibitors
#195Methods of expanding and selecting disease associated T-Cells
#196Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
#197Differentiation of pluripotent embryonic stem cells
#198Feeder layer and serum independent embryonic stem cells
#199Materials and methods relating to the production and maintenance of cell lines
#200Methods and compositions for increasing longevity and protein yield from a cell culture
#201In vitro fertilisation
#202Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation